End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.7 THB | +0.94% | +0.94% | +1.90% |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
Ratings chart - Surperformance
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.90% | 253M | - | ||
+20.88% | 213B | B+ | ||
-4.88% | 138B | B | ||
+15.47% | 58.75B | D+ | ||
+11.92% | 32.19B | C+ | ||
+4.89% | 31.03B | B+ | ||
+159.40% | 29.07B | D+ | ||
+29.31% | 21.08B | B- | ||
+1.51% | 13.19B | B | ||
-6.65% | 13.02B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- HUMAN Stock
- Ratings Humanica